For its fourth fiscal quarter (ending February 28), Constellation Brands Inc (NYSE: STZ) has reported a -197% decline in E.P.S. from $2.15 a year ago to $-2.09 in the current quarter. This result fell short […]
On 4/8/25, Humana Inc. (NYSE: HUM) stock enjoyed a major increase of 10.7%, closing at $281.95. Moreover, trading volume in this advance was exceptionally high at 281% of normal. Relative to the market the stock […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -10.6% on 4/8/25. The shares closed at $4.13. Moreover, trading volume in this decline was above average at 123% of normal. The stock has […]
REGENXBIO Inc (NASDAQ: RGNX) stock suffered a major decline of -10.5% on 4/8/25. The shares closed at $5.31. Trading volume in this decline was normal. The stock has been extremely weak relative to the market […]
Aehr Test Systems (NASDAQ: AEHR) has reported E.P.S. of $-0.02 for its third fiscal quarter (ending February 28) versus $-0.05 for the same period a year ago. This performance was $-0.06 short of the consensus […]
WD-40 Co (NASDAQ: WDFC) has reported earnings for its second fiscal quarter (ending February 28) of $2.20 versus $1.14 for the same period a year ago — an increase of 93%. This result exceeded the […]
SIGA Technologies Inc (NASDAQ: SIGA) stock enjoyed a major increase of 11.1% on 4/8/25. The shares closed at $5.92. Moreover, this advance was accompanied by exceptionally high trading volume at 244% of normal. The stock […]
Extremely important positive changes in investment behavior have recently occurred for Exact Sciences Corporation (NASDAQ: EXAS): the stock rose on very heavy volume, and its longer term price trend turned up. Exact Sciences Corporation (NASDAQ: […]
On 4/7/25, HUTCHMED (China) Limited (NASDAQ: HCM) stock suffered a major decline of -15.6%, closing at $12.14. Moreover, this decline was accompanied by exceptionally high trading volume at 224% of normal. Relative to the market […]
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock closed at $10.68 on 4/4/25 after a major decline of -11.4%. Moreover, unusually high trading volume at 164% of normal accompanied the decline. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research